Fundraising Fox

Iaso Therapeutics

East Lansing, US · Founded 2018 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

XH
Xuefei HuangExecutive Officer, Director
RF
Robert ForgeyExecutive Officer, Director
HK
Herbert KavunjaExecutive Officer
DP
Donald ParfetDirector
JW
Jeffrey WesleyDirector
SK
Steve KuemmerieDirector

Investors · 2

Michigan RiseEast Lansing · $50K – $150K
WMU Biosciences Research & Commercialization CenterKalamazoo · $100K – $250K

Reported raises · per SEC filings

Form D private placements
▶$570KraisedJan 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steve KuemmerieDirector
  • Robert ForgeyExecutive Officer, Director
  • Xuefei HuangExecutive Officer, Director
  • Donald ParfetDirector
  • Jeffrey WesleyDirector
Offering amount
$1.8M
Amount sold
$570K
Minimum investment
$25K
First sale
Jan 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$437.9KraisedJan 2023 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Xuefei HuangExecutive Officer, Director
  • Herbert KavunjaExecutive Officer
  • Jeffrey WesleyDirector
  • Donald ParfetDirector
  • Robert ForgeyExecutive Officer, Director
Offering amount
$1.3M
Amount sold
$437.9K
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.